FIELD: biotechnology.
SUBSTANCE: invention relates to a composition suitable for angiogenesis suppression in a subject, which is a human or an animal, containing peptide containing an amino acid sequence of glycine-arginine-glycine-cysteine(acid)-threonine-proline.
EFFECT: obtainment of a composition for angiogenesis suppression.
7 cl, 5 dwg, 5 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR INHIBITION OF CELLULAR ADHESION OR DIRECTION OF DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES | 2010 |
|
RU2642625C2 |
| INTEGRIN RECEPTOR ANTAGONISTS AND USE THEREOF | 2012 |
|
RU2721907C2 |
| TECHNIQUES AND COMPOSITIONS USED TO INHIBIT αβ-CAUSED ANGIOGENESIS | 1997 |
|
RU2195312C2 |
| RGD-CONTAINING PEPTIDOMIMETICS AND THEIR APPLICATION | 2009 |
|
RU2519736C2 |
| METHODS AND COMPOSITION USEFUL FOR ANGIOGENESIS INHIBITION | 1995 |
|
RU2162712C2 |
| PEPTIDE-BASED COMPOUNDS FOR DIRECTED TRANSPORT TO INTEGRIN RECEPTORS | 2002 |
|
RU2303042C2 |
| INHIBITORS OF INTEGRIN FOR TREATING OCULAR DISEASES | 2002 |
|
RU2311177C2 |
| METHOD FOR THE TREATMENT OF PROLIFERATIVE PROCESSES OF THE POSTERIOR SEGMENT OF THE EYE | 2018 |
|
RU2684927C1 |
| PEPTIDE COMPOUNDS | 2005 |
|
RU2393167C2 |
| METHOD FOR MODELING PROLIFERATIVE VITREORETINOPATHY | 2000 |
|
RU2182369C2 |
